Stem Cell Reports (Jan 2023)

Stress-induced reversible cell-cycle arrest requires PRC2/PRC1-mediated control of mitophagy in Drosophila germline stem cells and human iPSCs

  • Tommy H. Taslim,
  • Abdiasis M. Hussein,
  • Riya Keshri,
  • Julien R. Ishibashi,
  • Tung C. Chan,
  • Bich N. Nguyen,
  • Shuozhi Liu,
  • Daniel Brewer,
  • Stuart Harper,
  • Scott Lyons,
  • Ben Garver,
  • Jimmy Dang,
  • Nanditaa Balachandar,
  • Samriddhi Jhajharia,
  • Debra del Castillo,
  • Julie Mathieu,
  • Hannele Ruohola-Baker

Journal volume & issue
Vol. 18, no. 1
pp. 269 – 288

Abstract

Read online

Summary: Following acute genotoxic stress, both normal and tumorous stem cells can undergo cell-cycle arrest to avoid apoptosis and later re-enter the cell cycle to regenerate daughter cells. However, the mechanism of protective, reversible proliferative arrest, “quiescence,” remains unresolved. Here, we show that mitophagy is a prerequisite for reversible quiescence in both irradiated Drosophila germline stem cells (GSCs) and human induced pluripotent stem cells (hiPSCs). In GSCs, mitofission (Drp1) or mitophagy (Pink1/Parkin) genes are essential to enter quiescence, whereas mitochondrial biogenesis (PGC1α) or fusion (Mfn2) genes are crucial for exiting quiescence. Furthermore, mitophagy-dependent quiescence lies downstream of mTOR- and PRC2-mediated repression and relies on the mitochondrial pool of cyclin E. Mitophagy-dependent reduction of cyclin E in GSCs and in hiPSCs during mTOR inhibition prevents the usual G1/S transition, pushing the cells toward reversible quiescence (G0). This alternative method of G1/S control may present new opportunities for therapeutic purposes.

Keywords